NXGL Stock Analysis: Buy, Sell, or Hold?
NXGL - NexGel, Inc Common Stock
$1.42
-0.04 (-2.74%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 23, 2026
Get Alerted When NXGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NXGL is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NXGL is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NXGL is currently trading at $1.42, which is considered oversold relative to its 30-day fair value range of $1.53 to $1.72. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.9) compared to its historical average (10.4). Remarkably, the market is currently pricing in an annual earnings decline of 5.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NXGL is in a strong downtrend. The price is currently testing key support at $1.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+322.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NXGL is in a strong downtrend. The price is currently testing key support at $1.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+322.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.53 -
$1.72
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding NXGL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 322.5% below Wall St target ($6.00)
- WARNING: Recommendation downgraded due to -15.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.53 -
$1.72
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.40
Resistance Level
$1.74
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
8.88
Wall Street Target
$6.00
(+322.5%)
Revenue Growth (YoY)
-0.2%
Profit Margin
-24.7%
Valuation Discount vs History
-5.2% cheaper
PE vs Historical
8.9 vs 10.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.2%
(market-implied from PE analysis)
1-Year Target
$1.35
(-5%)
2-Year Target
$1.28
(-10%)
3-Year Target
$1.21
(-15%)
3-Yr Target (if PE normalizes)
(PE: 9→10)
$1.42
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.9 to 10.4
Stabilization Target:
$1.66
(+17.2%)
PE Expansion Potential:
+17.2%
Last updated: February 01, 2026 4:20 AM ET
Data refreshes hourly during market hours. Next update: 5:20 AM
Data refreshes hourly during market hours. Next update: 5:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott Robert Henry
SELL
7175 shares
2025-10-03
Adam R Levy
SELL
2400 shares
2025-10-03
Adam R Levy
SELL
1600 shares
2025-10-02
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced NXGL Option Strategies
Professional options setups generated by AI based on today's NXGL price and gamma walls.
